Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,756
datasets available to search
ShareScore release 0.9.0
Dataset results
2,756 results for “Head and neck”
Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers
ClinicalTrials.gov study NCT07072325. IPD Sharing: NO. Countries: 0. Publications: 13.
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01458392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
ClinicalTrials.gov study NCT00570232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
ClinicalTrials.gov study NCT03640195. IPD Sharing: NO. Countries: 0. Publications: 1.
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
ClinicalTrials.gov study NCT01044433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT00415194. IPD Sharing: Not stated. Countries: 21. Publications: 0.
A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer
ClinicalTrials.gov study NCT04144517. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
ClinicalTrials.gov study NCT01711541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
ClinicalTrials.gov study NCT01487733. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
ClinicalTrials.gov study NCT00468169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
ClinicalTrials.gov study NCT02331134. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04128696. IPD Sharing: YES. Countries: 26. Publications: 0.
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
ClinicalTrials.gov study NCT04217057. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
ClinicalTrials.gov study NCT02841748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies
ClinicalTrials.gov study NCT02369458. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimized Intensity Modulated Irradiation for Head and Neck Cancer
ClinicalTrials.gov study NCT00580983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase
ClinicalTrials.gov study NCT04905134. IPD Sharing: NO. Countries: 1. Publications: 0.
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT00513435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
ClinicalTrials.gov study NCT01183065. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
ClinicalTrials.gov study NCT04634825. IPD Sharing: NO. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.